دراسة انتشار (HIV)‎ و (HBV)‎ و (HCV)‎ و تقييم عوامل الخطورة المرتبطة عند مرضى التحال الدموي في مشافي دمشق، سوريا

الملخص EN

Patients with chronic renal failure (CRF) stay along time on hemodialysis (HD).

This invasive procedure by itself affects immunity of the patients who suffered from disturbance in the immune system and became more susceptible to viral infections, also HD machines which are being shared between different patients increase the risk of direct blood cross contamination.

Aim of the study : to investigate the incidence of HBV, HCV and HIV infections in patients with hemodialysis and identify associated risk factors.

Methods : A cross sectional - multicenter study included patients who had spent at least three months in hemodialysis.

HBV, HCV and HIV serologies were determined.

Patients' characteristics extracted from patient's records and the questionnaire designed for the study has filled out.

Results : We included 695 participants.

Mean age was 50.5 ± 15.5 years and 57% (n=396) were men.

The duration of dialysis was from one year to thirty years and the median duration was 6.07 ± 5.57.

after we excluded 7 patients who had HBV infection before starting hemodialysis, we found that the hepatitis B surface antigen, anti-HCV and anti-HIV antibody - antigen prevalence were respectively 3.2%, 22.1%, 0%.

Conclusion : The prevalence of HBV and HCV are high in hemodialysis patients.

There is urgent need for the implementation of preventive and control measures.